Long lasting response with trabectedin monotherapy in relapsed metastatic mesenchymal chondrosarcoma.
Ghazal TansirSameer RastogiAdarsh BarwadEkta DhamijaPublished in: Clinical sarcoma research (2020)
This report aims to present a comprehensive review into available and newer treatment choices for mesenchymal chondrosarcoma, and to highlight trabectedin monotherapy as a possible therapeutic option for mesenchymal chondrosarcoma in the relapsed setting.